Esperion Therapeutics Files 8-K
Ticker: ESPR · Form: 8-K · Filed: Mar 4, 2025 · CIK: 1434868
| Field | Detail |
|---|---|
| Company | Esperion Therapeutics, Inc. (ESPR) |
| Form Type | 8-K |
| Filed Date | Mar 4, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-k
TL;DR
Esperion filed an 8-K on March 4, 2025, for financial reporting.
AI Summary
Esperion Therapeutics, Inc. filed an 8-K on March 4, 2025, to report on its results of operations and financial condition, as well as to file financial statements and exhibits. The filing does not contain specific financial figures or operational details within the provided text, but indicates a standard reporting event for the company.
Why It Matters
This filing serves as an official update from Esperion Therapeutics, Inc. to the SEC, providing insights into their financial status and operational results.
Risk Assessment
Risk Level: low — This is a routine financial reporting filing with no new material events or changes disclosed in the provided text.
Key Players & Entities
- Esperion Therapeutics, Inc. (company) — Registrant
- 0001628280-25-009619 (filing_id) — Accession Number
- March 4, 2025 (date) — Filing Date
- Ann Arbor, MI (location) — Principal Executive Offices
FAQ
What is the primary purpose of this 8-K filing by Esperion Therapeutics, Inc.?
The primary purpose of this 8-K filing is to report on Esperion Therapeutics, Inc.'s results of operations and financial condition, and to file financial statements and exhibits.
When was this 8-K filing submitted to the SEC?
This 8-K filing was submitted to the SEC on March 4, 2025.
What is Esperion Therapeutics, Inc.'s principal executive office address?
Esperion Therapeutics, Inc.'s principal executive office is located at 3891 Ranchero Drive, Suite 150, Ann Arbor, MI 48108.
What is the Commission File Number for Esperion Therapeutics, Inc.?
The Commission File Number for Esperion Therapeutics, Inc. is 001-35986.
What is the Standard Industrial Classification (SIC) code for Esperion Therapeutics, Inc.?
The Standard Industrial Classification (SIC) code for Esperion Therapeutics, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 4, 2025 regarding Esperion Therapeutics, Inc. (ESPR).